Literature DB >> 86151

Demonstration of HLA restricted killer cells in patients with acute measles.

H W Kreth, V ter Meulen, G Eckert.   

Abstract

The relationship between HLA determinants on effector and target cells and cell-mediated cytotoxicity was studied using the release of 51Cr from measles virus-infected PHA-blasts. HLA compatibility between effector and target cells was not required if effector lymphocytes were derived from measles seropositive adults, from a patient with SSPE, and from children after live measles vaccination. Cytotoxicity was always abolished after removal of Fc receptor-bearing lymphoid cells. In these donors, the effect is, therefore, probably due to K cells. In contrast, lymphocytes from children with acute measles preferentially killed those virus-infected target cells with which they shared HLA antigens. Selective lytic activity was still observed after elimination of Fc receptor-bearing lymphoid cells. It is suggested that HLA-dependent killer cells represent specific cytotoxic T lymphocytes. These cells seem to be limited to the acute phase of measles.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86151     DOI: 10.1007/BF02152920

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  20 in total

1.  Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.

Authors:  B Härfast; T Andersson; P Perlmann
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

3.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

4.  Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations.

Authors:  E Kedar; M Ortiz de Landazuri; B Bonavida
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

5.  Cytotoxic antibody activity in measles and subacute sclerosing panencephalitis (SSPE) infection.

Authors:  R Kibler; A Deller; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

6.  A 51 Cr microassay technique for cell-mediated immunity to viruses.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

7.  Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.

Authors:  L H Perrin; R M Zinkernagel; M B Oldstone
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

8.  An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.

Authors:  T Andersson; V Stejskal; B Harfast
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.

Authors:  H W Kreth; G Wiegand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro.

Authors:  M A Wainberg; Y Markson; D W Weiss; F Doljanski
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more
  23 in total

1.  Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.

Authors:  C D Partidos; P Vohra; M W Steward
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

Review 3.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

4.  Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.

Authors:  R S van Binnendijk; J P Versteeg-van Oosten; M C Poelen; H F Brugghe; P Hoogerhout; A D Osterhaus; F G Uytdehaag
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Demonstration of virus-specific CD8+ memory T cells in measles-seropositive individuals by in vitro peptide stimulation.

Authors:  R Nanan; C Carstens; H W Kreth
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus.

Authors:  M J Appel; W R Shek; B A Summers
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.

Authors:  A Jaye; A F Magnusen; A D Sadiq; T Corrah; H C Whittle
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

9.  Killing of measles virus-infected cells by human cytotoxic T cells.

Authors:  C J Lucas; W E Biddison; D L Nelson; S Shaw
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Generation of cytolytic T-cell cultures displaying measles virus specificity and human histocompatibility leukocyte antigen restriction.

Authors:  K K Sethi; I Stroehmann; H Brandis
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.